A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations

Gut. 2006 Jun;55(6):901-2. doi: 10.1136/gut.2006.091967.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Drug Combinations
  • Fatty Liver / drug therapy*
  • Humans
  • Insulin Resistance*
  • Phospholipids / therapeutic use
  • Silybin
  • Silymarin / therapeutic use
  • Vitamin E / therapeutic use

Substances

  • Drug Combinations
  • Phospholipids
  • Silymarin
  • Vitamin E
  • Silybin